Vickie S. Reed - 27 Apr 2022 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Director
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Vickie S. Reed
Issuer symbol
EVOK
Transactions as of
27 Apr 2022
Net transactions value
$0
Form type
4
Filing time
28 Apr 2022, 19:20:10 UTC
Previous filing
18 Jan 2022
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +58,000 $0.000000 58,000 27 Apr 2022 Common Stock 58,000 $0.6600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the reporting person's continued service to the Issuer through such vesting date.